Literature DB >> 30054694

HILIC/ESI-MS determination of gangliosides and other polar lipid classes in renal cell carcinoma and surrounding normal tissues.

Roman Hájek1, Miroslav Lísa1, Maria Khalikova1, Robert Jirásko1, Eva Cífková1, Vladimír Študent2, David Vrána3, Lukáš Opálka4, Kateřina Vávrová4, Marcel Matzenauer3, Bohuslav Melichar3, Michal Holčapek5.   

Abstract

Negative-ion hydrophilic liquid chromatography-electrospray ionization mass spectrometry (HILIC/ESI-MS) method has been optimized for the quantitative analysis of ganglioside (GM3) and other polar lipid classes, such as sulfohexosylceramides (SulfoHexCer), sulfodihexosylceramides (SulfoHex2Cer), phosphatidylglycerols (PG), phosphatidylinositols (PI), lysophosphatidylinositols (LPI), and phosphatidylserines (PS). The method is fully validated for the quantitation of the studied lipids in kidney normal and tumor tissues of renal cell carcinoma (RCC) patients based on the lipid class separation and the coelution of lipid class internal standard with the species from the same lipid class. The raw data are semi-automatically processed using our software LipidQuant and statistically evaluated using multivariate data analysis (MDA) methods, which allows the complete differentiation of both groups with 100% specificity and sensitivity. In total, 21 GM3, 28 SulfoHexCer, 26 SulfoHex2Cer, 10 PG, 19 PI, 4 LPI, and 7 PS are determined in the aqueous phase of lipidomic extracts from kidney tumor tissue samples and surrounding normal tissue samples of 20 RCC patients. S-plots allow the identification of most upregulated (PI 40:5, PI 40:4, GM3 34:1, and GM3 42:2) and most downregulated (PI 32:0, PI 34:0, PS 36:4, and LPI 16:0) lipids, which are primarily responsible for the differentiation of tumor and normal groups. Another confirmation of most dysregulated lipids is performed by the calculation of fold changes together with T and p values to highlight their statistical significance. The comparison of HILIC/ESI-MS data and matrix-assisted laser desorption/ionization mass spectrometric imaging (MALDI-MSI) data confirms that lipid dysregulation patterns are similar for both methods. Graphical abstract ᅟ.

Entities:  

Keywords:  Gangliosides; HILIC; Lipidomics; Lipids; Mass spectrometry; Renal cell carcinoma; Tumor tissues

Mesh:

Substances:

Year:  2018        PMID: 30054694     DOI: 10.1007/s00216-018-1263-8

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  5 in total

Review 1.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

2.  Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.

Authors:  Joanna Nizioł; Krzysztof Ossoliński; Brian P Tripet; Valérie Copié; Adrian Arendowski; Tomasz Ruman
Journal:  Anal Bioanal Chem       Date:  2020-07-13       Impact factor: 4.142

3.  Comprehensive Identification of Glycosphingolipids in Human Plasma Using Hydrophilic Interaction Liquid Chromatography-Electrospray Ionization Mass Spectrometry.

Authors:  Karel Hořejší; Robert Jirásko; Michaela Chocholoušková; Denise Wolrab; David Kahoun; Michal Holčapek
Journal:  Metabolites       Date:  2021-02-26

4.  Laser Ablation Remote-Electrospray Ionisation Mass Spectrometry (LARESI MSI) Imaging-New Method for Detection and Spatial Localization of Metabolites and Mycotoxins Produced by Moulds.

Authors:  Justyna Szulc; Tomasz Ruman
Journal:  Toxins (Basel)       Date:  2020-11-18       Impact factor: 4.546

5.  Localization of Metabolites of Human Kidney Tissue with Infrared Laser-Based Selected Reaction Monitoring Mass Spectrometry Imaging and Silver-109 Nanoparticle-Based Surface Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.

Authors:  Joanna Nizioł; Jan Sunner; Iwona Beech; Krzysztof Ossoliński; Anna Ossolińska; Tadeusz Ossoliński; Aneta Płaza; Tomasz Ruman
Journal:  Anal Chem       Date:  2020-02-28       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.